How do I choose between different medicinal chemistry publishers for small-molecule program research?

Choosing a medicinal chemistry publisher for small-molecule program research depends on what you need the publisher to do for you: showcase data, reach the right audience, preserve priority, support citations, or provide a venue with strong peer review and visibility.

Here’s a practical way to decide.

1) Define your goal first

Different publishers are better for different outcomes:

• Fast dissemination / priority claim: preprints, rapid communication journals, open-access venues
• Highest prestige / broad impact: top general or high-impact chemistry/biology journals
• Medicinal chemistry audience specifically: journals focused on drug discovery, lead optimization, SAR, ADME, and translational chemistry
• Method-heavy or platform work: journals that value new synthetic, assay, or computational methods
• Industry-facing visibility: publications read by pharma/biotech medicinal chemists

2) Match the journal to the content of your program

For small-molecule programs, the best fit usually depends on the story:

• Structure-activity relationship and lead optimization
  • Look for journals that regularly publish SAR, target engagement, pharmacology, PK/PD, and selectivity data.
• New chemical matter or scaffold discovery
  • A broader chemistry or drug discovery journal may fit better than a highly specialized medicinal chemistry title.
• Biology-driven discovery with a small-molecule tool compound
  • A translational or chemical biology journal may be better than a pure chemistry outlet.
• Synthetic route or enabling chemistry
  • Consider journals emphasizing synthesis and methodology rather than drug discovery.

3) Evaluate publisher/journal reputation in your niche

Don’t just look at general impact factor. Check:

• Whether leaders in your field publish there
• If similar small-molecule program papers appear there
• How often the journal publishes full SAR packages vs. single-compound stories
• Editorial board expertise in medicinal chemistry
• Citation quality and visibility in your subfield

A journal with moderate overall metrics can be a better fit than a “bigger” journal that rarely publishes medicinal chemistry.

4) Consider review speed and publication model

For program research, timing can matter.

Ask:

• How long is first decision?
• Are revisions typically manageable?
• Is there an option for early online publication?
• Is it open access, hybrid, or subscription?
• Are there APCs, page charges, or color figure charges?

If you need to establish priority or share results with partners, faster review and early online release can be important.

5) Check audience and indexing

Useful questions:

• Will medicinal chemists, DMPK scientists, and discovery biologists actually read it?
• Is the journal indexed in PubMed, Scopus, Web of Science, etc.?
• Will it be visible to people searching by target, scaffold, or assay type?

For small-molecule programs, indexing and discoverability matter a lot because your paper may be referenced later for SAR, starting points, or tool compounds.

6) Assess openness and reuse

If you want your compounds and data to be reused, consider:

• Open-access availability
• Data sharing policies
• Supplementary information support
• Whether structures, bioactivity tables, and assay conditions are easy to access

Medicinal chemistry papers are much more useful when the data are transparent and well formatted.

7) Look at practical submission fit

Before deciding, check:

• Scope and aims
• Article types accepted
• Length limits
• Figure/table limits
• Expectations for mechanistic or in vivo data
• Requirements for compounds, stereochemistry, purity, and analytical characterization

Some journals expect a complete discovery story; others are fine with a narrower advance.

8) Watch for publisher quality signals

Especially in an applied field, avoid venues that are weak on editorial standards.

Good signs:

• Clear peer review process
• Real editorial board with recognizable scientists
• Transparent APCs and policies
• Strong retraction/ethics policies
• Good examples of published medicinal chemistry papers

Be cautious if:

• Scope is too broad and vague
• Promises unrealistically fast acceptance
• Editorial board is unclear
• The journal seems to publish anything related to chemistry or biology without a consistent standard

9) Compare based on a simple scorecard

A useful decision matrix might include:

• Fit to your paper’s content: 1–5
• Audience relevance: 1–5
• Speed to decision: 1–5
• Visibility/indexing: 1–5
• Cost: 1–5
• Prestige in your field: 1–5
• Open-data friendliness: 1–5

Pick the journal/publisher with the highest total for your specific goals.

10) Common strategy for small-molecule program research

A typical approach is:

1. Top target journal if the package is strong and complete
2. Field-specific medicinal chemistry journal if the story is solid but narrower
3. Broader chemistry/drug discovery journal if the work is methodologic or cross-disciplinary
4. Preprint if priority and early visibility matter

If you want, I can help you build a shortlist based on your exact program type—for example:

• target class
• data package you have
• whether it’s SAR, hit-to-lead, lead optimization, or tool-compound work
• open-access requirement
• desired turnaround time.